These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 7968664

  • 1. Effects of temperature on the bactericidal activities of ciprofloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis.
    Parte AC, Smith JT.
    Microbios; 1994; 79(319):87-95. PubMed ID: 7968664
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model.
    Lister PD.
    Clin Infect Dis; 2001 Mar 15; 32 Suppl 1():S33-8. PubMed ID: 11249827
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Ryan BM, Mazzucco CE, Lawrence LE, Ho H, Warr G, Barrett JF, Frosco M.
    Eur J Clin Microbiol Infect Dis; 2002 Jan 15; 21(1):27-34. PubMed ID: 11913498
    [Abstract] [Full Text] [Related]

  • 10. ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.
    Firsov AA, Vostrov SN, Lubenko IY, Arzamastsev AP, Portnoy YA, Zinner SH.
    J Antimicrob Chemother; 2004 Jul 15; 54(1):178-86. PubMed ID: 15190041
    [Abstract] [Full Text] [Related]

  • 11. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
    Soriano A, Jurado A, Marco F, Almela M, Ortega M, Mensa J.
    Rev Esp Quimioter; 2005 Jun 15; 18(2):168-72. PubMed ID: 16130039
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
    Kang SL, Rybak MJ, McGrath BJ, Kaatz GW, Seo SM.
    Antimicrob Agents Chemother; 1994 Dec 15; 38(12):2702-9. PubMed ID: 7695250
    [Abstract] [Full Text] [Related]

  • 13. Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.
    Chaudhry AZ, Knapp CC, Sierra-Madero J, Washington JA.
    Antimicrob Agents Chemother; 1990 Sep 15; 34(9):1843-5. PubMed ID: 2285304
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model.
    Nguyen HA, Grellet J, Paillard D, Dubois V, Quentin C, Saux MC.
    J Antimicrob Chemother; 2006 May 15; 57(5):883-90. PubMed ID: 16533826
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
    Gilbert DN, Kohlhepp SJ, Slama KA, Grunkemeier G, Lewis G, Dworkin RJ, Slaughter SE, Leggett JE.
    Antimicrob Agents Chemother; 2001 Mar 15; 45(3):883-92. PubMed ID: 11181375
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of levofloxacin, ofloxacin and other quinolones against coagulase-negative staphylococci.
    Foleno BD, Lafredo SC, Fu KP.
    Chemotherapy; 1993 Mar 15; 39(2):120-3. PubMed ID: 8458244
    [Abstract] [Full Text] [Related]

  • 19. Quinolone resistance in Staphylococci: activities of new nonfluorinated quinolones against molecular targets in whole cells and clinical isolates.
    Roychoudhury S, Catrenich CE, McIntosh EJ, McKeever HD, Makin KM, Koenigs PM, Ledoussal B.
    Antimicrob Agents Chemother; 2001 Apr 15; 45(4):1115-20. PubMed ID: 11257024
    [Abstract] [Full Text] [Related]

  • 20. The importance of oxygen in the killing of bacteria by ofloxacin and ciprofloxacin.
    Morrissey I, Smith JT.
    Microbios; 1994 Apr 15; 79(318):43-53. PubMed ID: 8078420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.